• Home
  • Pharmaceuticals and Healthcare
Recombinant DNA (rDNA) Technology Market - Global Outlook and Forecast 2021-2027

Recombinant DNA (rDNA) Technology Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687535 | No. of Pages: 103 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Recombinant DNA (rDNA) Technology in Global, including the following market information:
Global Recombinant DNA (rDNA) Technology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Recombinant DNA (rDNA) Technology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant DNA (rDNA) Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant DNA (rDNA) Technology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Recombinant DNA (rDNA) Technology Market Segment Percentages, By Type, 2020 (%)
Expression System
Cloning Vector

China Recombinant DNA (rDNA) Technology Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Recombinant DNA (rDNA) Technology Market Segment Percentages, By Application, 2020 (%)
Biotechnology and Pharmaceutical Companies
Academic and Government Research Institutes
Other

Global Recombinant DNA (rDNA) Technology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Recombinant DNA (rDNA) Technology Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Recombinant DNA (rDNA) Technology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Recombinant DNA (rDNA) Technology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
F. Hoffmann-La Roche Ltd (Genentech, Inc)
Profacgen
Amgen Inc
Novartis AG
GenScript
Pfizer Inc
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Biocon
GlaxoSmithKline plc
New England Biolabs.
Cibus
Monsanto Company
Horizon Discovery Group PLC
1 Introduction to Research & Analysis Reports
    1.1 Recombinant DNA (rDNA) Technology Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Recombinant DNA (rDNA) Technology Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Recombinant DNA (rDNA) Technology Overall Market Size
    2.1 Global Recombinant DNA (rDNA) Technology Market Size: 2021 VS 2027
    2.2 Global Recombinant DNA (rDNA) Technology Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Recombinant DNA (rDNA) Technology Players in Global Market
    3.2 Top Global Recombinant DNA (rDNA) Technology Companies Ranked by Revenue
    3.3 Global Recombinant DNA (rDNA) Technology Revenue by Companies
    3.4 Top 3 and Top 5 Recombinant DNA (rDNA) Technology Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Recombinant DNA (rDNA) Technology Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Recombinant DNA (rDNA) Technology Players in Global Market
        3.6.1 List of Global Tier 1 Recombinant DNA (rDNA) Technology Companies
        3.6.2 List of Global Tier 2 and Tier 3 Recombinant DNA (rDNA) Technology Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Recombinant DNA (rDNA) Technology Market Size Markets, 2021 & 2027
        4.1.2 Expression System
        4.1.3 Cloning Vector
    4.2 By Type - Global Recombinant DNA (rDNA) Technology Revenue & Forecasts
        4.2.1 By Type - Global Recombinant DNA (rDNA) Technology Revenue, 2016-2021
        4.2.2 By Type - Global Recombinant DNA (rDNA) Technology Revenue, 2022-2027
        4.2.3 By Type - Global Recombinant DNA (rDNA) Technology Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Recombinant DNA (rDNA) Technology Market Size, 2021 & 2027
        5.1.2 Biotechnology and Pharmaceutical Companies
        5.1.3 Academic and Government Research Institutes
        5.1.4 Other
    5.2 By Application - Global Recombinant DNA (rDNA) Technology Revenue & Forecasts
        5.2.1 By Application - Global Recombinant DNA (rDNA) Technology Revenue, 2016-2021
        5.2.2 By Application - Global Recombinant DNA (rDNA) Technology Revenue, 2022-2027
        5.2.3 By Application - Global Recombinant DNA (rDNA) Technology Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Recombinant DNA (rDNA) Technology Market Size, 2021 & 2027
    6.2 By Region - Global Recombinant DNA (rDNA) Technology Revenue & Forecasts
        6.2.1 By Region - Global Recombinant DNA (rDNA) Technology Revenue, 2016-2021
        6.2.2 By Region - Global Recombinant DNA (rDNA) Technology Revenue, 2022-2027
        6.2.3 By Region - Global Recombinant DNA (rDNA) Technology Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Recombinant DNA (rDNA) Technology Revenue, 2016-2027
        6.3.2 US Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.3.3 Canada Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.3.4 Mexico Recombinant DNA (rDNA) Technology Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Recombinant DNA (rDNA) Technology Revenue, 2016-2027
        6.4.2 Germany Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.3 France Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.4 U.K. Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.5 Italy Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.6 Russia Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.7 Nordic Countries Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.4.8 Benelux Recombinant DNA (rDNA) Technology Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Recombinant DNA (rDNA) Technology Revenue, 2016-2027
        6.5.2 China Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.5.3 Japan Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.5.4 South Korea Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.5.5 Southeast Asia Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.5.6 India Recombinant DNA (rDNA) Technology Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Recombinant DNA (rDNA) Technology Revenue, 2016-2027
        6.6.2 Brazil Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.6.3 Argentina Recombinant DNA (rDNA) Technology Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Recombinant DNA (rDNA) Technology Revenue, 2016-2027
        6.7.2 Turkey Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.7.3 Israel Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.7.4 Saudi Arabia Recombinant DNA (rDNA) Technology Market Size, 2016-2027
        6.7.5 UAE Recombinant DNA (rDNA) Technology Market Size, 2016-2027
7 Players Profiles
    7.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
        7.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Corporate Summary
        7.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
        7.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Major Product Offerings
        7.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Key News
    7.2 Profacgen
        7.2.1 Profacgen Corporate Summary
        7.2.2 Profacgen Business Overview
        7.2.3 Profacgen Recombinant DNA (rDNA) Technology Major Product Offerings
        7.2.4 Profacgen Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.2.5 Profacgen Key News
    7.3 Amgen Inc
        7.3.1 Amgen Inc Corporate Summary
        7.3.2 Amgen Inc Business Overview
        7.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Major Product Offerings
        7.3.4 Amgen Inc Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.3.5 Amgen Inc Key News
    7.4 Novartis AG
        7.4.1 Novartis AG Corporate Summary
        7.4.2 Novartis AG Business Overview
        7.4.3 Novartis AG Recombinant DNA (rDNA) Technology Major Product Offerings
        7.4.4 Novartis AG Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.4.5 Novartis AG Key News
    7.5 GenScript
        7.5.1 GenScript Corporate Summary
        7.5.2 GenScript Business Overview
        7.5.3 GenScript Recombinant DNA (rDNA) Technology Major Product Offerings
        7.5.4 GenScript Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.5.5 GenScript Key News
    7.6 Pfizer Inc
        7.6.1 Pfizer Inc Corporate Summary
        7.6.2 Pfizer Inc Business Overview
        7.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Major Product Offerings
        7.6.4 Pfizer Inc Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.6.5 Pfizer Inc Key News
    7.7 Novo Nordisk A/S
        7.7.1 Novo Nordisk A/S Corporate Summary
        7.7.2 Novo Nordisk A/S Business Overview
        7.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Major Product Offerings
        7.4.4 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.7.5 Novo Nordisk A/S Key News
    7.8 Eli Lilly and Company
        7.8.1 Eli Lilly and Company Corporate Summary
        7.8.2 Eli Lilly and Company Business Overview
        7.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Major Product Offerings
        7.8.4 Eli Lilly and Company Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.8.5 Eli Lilly and Company Key News
    7.9 Sanofi
        7.9.1 Sanofi Corporate Summary
        7.9.2 Sanofi Business Overview
        7.9.3 Sanofi Recombinant DNA (rDNA) Technology Major Product Offerings
        7.9.4 Sanofi Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.9.5 Sanofi Key News
    7.10 Biocon
        7.10.1 Biocon Corporate Summary
        7.10.2 Biocon Business Overview
        7.10.3 Biocon Recombinant DNA (rDNA) Technology Major Product Offerings
        7.10.4 Biocon Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.10.5 Biocon Key News
    7.11 GlaxoSmithKline plc
        7.11.1 GlaxoSmithKline plc Corporate Summary
        7.11.2 GlaxoSmithKline plc Business Overview
        7.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Major Product Offerings
        7.11.4 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.11.5 GlaxoSmithKline plc Key News
    7.12 New England Biolabs.
        7.12.1 New England Biolabs. Corporate Summary
        7.12.2 New England Biolabs. Business Overview
        7.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Major Product Offerings
        7.12.4 New England Biolabs. Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.12.5 New England Biolabs. Key News
    7.13 Cibus
        7.13.1 Cibus Corporate Summary
        7.13.2 Cibus Business Overview
        7.13.3 Cibus Recombinant DNA (rDNA) Technology Major Product Offerings
        7.13.4 Cibus Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.13.5 Cibus Key News
    7.14 Monsanto Company
        7.14.1 Monsanto Company Corporate Summary
        7.14.2 Monsanto Company Business Overview
        7.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Major Product Offerings
        7.14.4 Monsanto Company Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.14.5 Monsanto Company Key News
    7.15 Horizon Discovery Group PLC
        7.15.1 Horizon Discovery Group PLC Corporate Summary
        7.15.2 Horizon Discovery Group PLC Business Overview
        7.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Major Product Offerings
        7.15.4 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Revenue in Global (2016-2021)
        7.15.5 Horizon Discovery Group PLC Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com